REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Major Program
Supportive Care and Symptom Management
Sponsor
Dana-Farber Cancer Institute
Status
Not yet recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT06710548
The purpose of this study is to see whether a psychosocial intervention (REVITALIZE) reduces fatigue and its impact on daily life and activities for participants with ovarian cancer taking PARP inhibitors.

The name of the study groups in this research study are:

* REVITALIZE
* Enhanced Usual Care (EUC)
Intervention
Revitalize Intervention
Condition
Ovarian Cancer, Advanced Ovarian Carcinoma
Investigators
Alexi Wright, MD, MPH

See list of participating sites